Summary:
The purpose of this study is to evaluate the effectiveness of aripriprazole medication with patients with Schizophrenia. We have both inpatient and outpatient facilities. Patients will be compensated for each study visit.
Qualified Participants Must:
• Between 18 and 65 years of age
•
Have been diagnosed with Schizophrenia.